Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Redhill Gains Most in 7 Months on RHB-102 Clinical Trial Success

Redhill Biopharma Ltd. surged the most in almost seven months after the Israeli pharmaceutical company said a clinical trial of its RHB-102 drug against nausea and vomiting in cancer treatments was successful.

The shares jumped as much as 22 percent, the biggest intraday increase since September 2011, and were 16 percent up at 2.50 shekels as of 10:38 a.m. in Tel Aviv, giving the company a market value of 131 million shekels ($35 million).

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.